NAV on (30 Apr 2026 )
₹35.32 ▲
(+0.12%)
Fund Size
₹1229.42 Crores
1Y Returns
3.81 %
The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Launch Date
December 4, 2015
Fund Manager
Mr. Rajat Srivastava
Initial Price
10
AUM Fund
1229.42 Cr
Min investment
Rs 5000
Expense Ratio
0.72%
Daily - Rs. 150/- and in multiples of Re. 1/- thereafter. Minimum 12 installments.Monthly - Rs. 150/- and multiple of Re. 1/- thereafter. Minimum 12 installments.Monthly - Rs. 1000/- and multiple of Re. 1/- thereafter. Minimum 6 installments.Quarterly - Rs. 1000/- and multiple of Re. 1/- thereafter. Minimum 6 installments.Quarterly - Rs. 1500/- and multiple of Re. 1/- thereafter. Minimum 4 installments.
0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.
1 Month
+6.98%
6 Months
-2.46%
1 Year
+3.81%
2 Years (CAGR)
+10.83%
3 Years (CAGR)
+23.90%
5 Years (CAGR)
+15.10%
| Equity / Mid Cap funds | 1Y | 3Y | Fund Size (Cr) |
|---|---|---|---|
| 15.19% | 0.00% | ₹1976.86 | |
| 15.19% | 0.00% | ₹1976.86 | |
| 13.84% | 0.00% | ₹1976.86 | |
| 13.84% | 0.00% | ₹1976.86 | |
| 12.44% | 0.00% | ₹556.42 |
Q: What is the current NAV of Tata India Pharma & HealthCare Fund - Direct Plan - IDCW-Reinvestment?
A: The latest NAV of Tata India Pharma & HealthCare Fund - Direct Plan - IDCW-Reinvestment is ₹ 35.32 as on 30 Apr 2026.
Q: What type of mutual fund is Tata India Pharma & HealthCare Fund - Direct Plan - IDCW-Reinvestment?
A: Tata India Pharma & HealthCare Fund - Direct Plan - IDCW-Reinvestment is a 'Equity - Pharma' type mutual fund managed by 'Tata Asset Management Ltd.'.
Q: What is the expense ratio of Tata India Pharma & HealthCare Fund - Direct Plan - IDCW-Reinvestment?
A: The expense ratio of Tata India Pharma & HealthCare Fund - Direct Plan - IDCW-Reinvestment is 0.72%, which impacts overall returns.
Q: Who manages Tata India Pharma & HealthCare Fund - Direct Plan - IDCW-Reinvestment?
A: Tata India Pharma & HealthCare Fund - Direct Plan - IDCW-Reinvestment is managed by Mr. Rajat Srivastava, who oversees investment strategy and portfolio decisions.
Q: Is Tata India Pharma & HealthCare Fund - Direct Plan - IDCW-Reinvestment a good investment?
A: Tata India Pharma & HealthCare Fund - Direct Plan - IDCW-Reinvestment may be suitable depending on your financial goals, risk appetite, and investment horizon. Always evaluate fund performance and consult a financial advisor.
Q: What is the exit load of Tata India Pharma & HealthCare Fund - Direct Plan - IDCW-Reinvestment?
A: The exit load of Tata India Pharma & HealthCare Fund - Direct Plan - IDCW-Reinvestment is 0.25% of NAV if redeemed/switched out before 30 days from the date of allotment., applicable if redeemed within the specified period.
Q: How is Tata India Pharma & HealthCare Fund - Direct Plan - IDCW-Reinvestment taxed?
A: Taxation depends on the fund type (equity/debt) and holding period as per Indian tax laws.
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback